Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study

J Korean Med Sci. 2022 Feb 21;37(7):e58. doi: 10.3346/jkms.2022.37.e58.

Abstract

Guillain-Barre syndrome (GBS) is an immune-mediated acute polyradiculoneuropathy and commonly occurs after a preceding infection or immunization sequalae. Following the severe acute respiratory syndrome-coronavirus-2 virus pandemic with co-introduction of massive vaccinations, several GBS cases associated with coronavirus disease 2019 (COVID-19) infection per se or after vaccination for COVID-19 were reported internationally. Herein, we report two cases of Korean GBS presenting with tetraplegia after two different COVID-19 vaccinations (42-year old man by AstraZeneca and 48-year woman by Pfizer vaccines) within four weeks after vaccination. The patients were diagnosed with clinical examination, serial electromyography, and compatible laboratory results and improved after comprehensive rehabilitative treatment and intravenous immunoglobulin therapy. Furthermore, we performed an electrodiagnostic follow-up study of each case to examine their unique characteristics.

Keywords: COVID-19 Vaccination; Case Report; Comprehensive Rehabilitation Therapy; Electrodiagnosis; Guillain-Barre Syndrome (GBS).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • BNT162 Vaccine / adverse effects*
  • BNT162 Vaccine / immunology
  • COVID-19 / prevention & control
  • ChAdOx1 nCoV-19 / adverse effects*
  • ChAdOx1 nCoV-19 / immunology
  • Electromyography
  • Female
  • Guillain-Barre Syndrome / pathology*
  • Guillain-Barre Syndrome / rehabilitation
  • Guillain-Barre Syndrome / therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Male
  • Middle Aged
  • Quadriplegia / pathology*
  • Quadriplegia / rehabilitation
  • Quadriplegia / therapy
  • SARS-CoV-2 / immunology
  • Vaccination / adverse effects*

Substances

  • Immunoglobulins, Intravenous
  • ChAdOx1 nCoV-19
  • BNT162 Vaccine